Paperpal Prime Logo

Oncogematologiya : Impact Factor & More

eISSN: 2413-4023pISSN: 1818-8346
JournalOpen Access

Key Metrics

CiteScore
0.4
SJR
Q4Oncology
SNIP
0.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncogematologiya

Oncogematologiya Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ABV-press Publishing house, LLC
Language Russian
Publication Time10
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Oncogematologiya ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncogematologiya

Luspatercept in the treatment of patients with lower-risk myelodysplastic neoplasms
  • 30 Sep 2026
  • Oncohematology
<i>BRAF</i>- and <i>MEK</i>-inhibitors in the treatment of Langerhans cell histiocytosis in children and adults: molecular basis, clinical experience and unresolved issues
  • 30 Sep 2026
  • Oncohematology
Differentially expressed genes in CD34<sup>+</sup> cells in Ph-negative myeloproliferative neoplasms: bioinformatics meta-analysis of three independent studies
  • 30 Sep 2026
  • Oncohematology
Real-world management of patients with paroxysmal nocturnal hemoglobinuria in Russia: outcomes of the multicenter retrospective RADAR-PNH study
  • 30 Sep 2026
  • Oncohematology
Autologous hematopoietic stem cell transplantation in patients with HIV and lymphoproliferative disorders
  • 30 Sep 2026
  • Oncohematology
Population-based study of newly diagnosed multiple myeloma in Moscow: data from the Moscow City Cancer Registry (2022–2025)
  • 30 Sep 2026
  • Oncohematology
Luspatercept in the treatment of patients with lower-risk myelodysplastic neoplasms
  • 30 Sep 2026
  • Oncohematology
<i>BRAF</i>- and <i>MEK</i>-inhibitors in the treatment of Langerhans cell histiocytosis in children and adults: molecular basis, clinical experience and unresolved issues
  • 30 Sep 2026
  • Oncohematology
Differentially expressed genes in CD34<sup>+</sup> cells in Ph-negative myeloproliferative neoplasms: bioinformatics meta-analysis of three independent studies
  • 30 Sep 2026
  • Oncohematology
Real-world management of patients with paroxysmal nocturnal hemoglobinuria in Russia: outcomes of the multicenter retrospective RADAR-PNH study
  • 30 Sep 2026
  • Oncohematology
Autologous hematopoietic stem cell transplantation in patients with HIV and lymphoproliferative disorders
  • 30 Sep 2026
  • Oncohematology
Population-based study of newly diagnosed multiple myeloma in Moscow: data from the Moscow City Cancer Registry (2022–2025)
  • 30 Sep 2026
  • Oncohematology

FAQs on Oncogematologiya